Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nurtec
Biotech
Biohaven veers toward Kv7 platform following Pfizer sale
Biohaven is looking to reinvigorate itself without reinvention, prioritizing its recently acquired Kv7 platform in the race for new epilepsy meds.
Max Bayer
Oct 4, 2022 11:48am
Biohaven flunks ALS trial, the 2nd gut punch since Nurtec sale
Sep 29, 2022 10:30am
Welcome to new (Bio) Haven: CEO hopes to strike gold twice
May 11, 2022 11:11am
Starting gun? $11B M&A domino falls as Pfizer scoops up Biohaven
May 10, 2022 11:34am
